IDXX vs NCLH · P/E 40, rev $2.36B vs P/E 16, rev $4.97B
IDEXX Laboratories Inc (IDXX) versus Norwegian Cruise Line Holdings Ltd (NCLH) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Norwegian Cruise Line Holdings Ltd (NCLH) is a travel services company listed on NYSE.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported NCLH revenue for 2026-06-30 was $4.97B. Net income was $327.2M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
Not investment advice. Open the IDXX and NCLH stock pages for the full models.
Not investment advice.